» Articles » PMID: 11574281

Interleukin-7: Master Regulator of Peripheral T-cell Homeostasis?

Overview
Journal Trends Immunol
Date 2001 Sep 28
PMID 11574281
Citations 104
Authors
Affiliations
Soon will be listed here.
Abstract

Recent evidence has implicated interleukin-7 (IL-7) as a master regulator of T-cell homeostasis, based upon its essential role in the homeostatic expansion of naive T-cell populations in response to low-affinity antigens (Ags) and its capacity to enhance dramatically the expansion of peripheral T-cell populations in response to high-affinity Ags. Furthermore, T-cell-depleted humans have a unique inverse relationship between the peripheral CD4(+) T-cell count and the level of circulating IL-7. Together, these data suggest that increased amounts of IL-7 become available following T-cell depletion, thus, enhancing the high- and low-affinity Ag-driven expansion of the population of residual, mature T cells and boosting thymic regenerative capacity, as a means to restore T-cell homeostasis.

Citing Articles

Optimized BCMA/CS1 bispecific TRuC-T cells secreting IL-7 and CCL21 robustly control multiple myeloma.

Li M, Zheng R, Liu Z, Zhang P, Zhu T, Xin X Front Immunol. 2025; 15():1502936.

PMID: 39776916 PMC: 11703830. DOI: 10.3389/fimmu.2024.1502936.


Tumor cells ectopically expressing the membrane-bound form of IL-7 develop an antitumor immune response efficiently in a colon carcinoma model.

Shin H, Kim H, Kwon S, Lee H, Lee J, Kim Y Mol Cells. 2025; 48(2):100175.

PMID: 39743142 PMC: 11873615. DOI: 10.1016/j.mocell.2024.100175.


Comprehensive analysis of serum cytokines in patients with multiple myeloma before and after lenalidomide and dexamethasone.

Tachita T, Ri M, Aoki S, Asano A, Kanamori T, Totani H Cancer Med. 2024; 13(14):e70019.

PMID: 39031503 PMC: 11259000. DOI: 10.1002/cam4.70019.


The Role of Chemokines in Orchestrating the Immune Response to Pancreatic Ductal Adenocarcinoma.

Lekan A, Weiner L Cancers (Basel). 2024; 16(3).

PMID: 38339310 PMC: 10854906. DOI: 10.3390/cancers16030559.


A mechanistically novel peptide agonist of the IL-7 receptor that addresses limitations of IL-7 cytokine therapy.

Dower W, Park A, Bakker A, Cwirla S, Pongtornpipat P, Williams B PLoS One. 2023; 18(10):e0286834.

PMID: 37874823 PMC: 10597491. DOI: 10.1371/journal.pone.0286834.